[ET Net News Agency, 4 December 2023] Daiwa raised its target price for CSPC Pharma
(01093) to HKD7.6 from HKD6.5 and maintained its "outperform" rating.
The research house said its 2023-25 EPS are 2-3% behind consensus as it is more
conservative on new products' sales ramp-up. (RC)